Business Context and Reporting Period
This Form 8-K Current Report was filed by The Campbell's Company on September 5, 2025, covering events occurring on September 2 and September 3, 2025. The filing addresses executive leadership changes within the company's finance and accounting functions.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel appointments and associated compensation arrangements.
Material Changes
The primary material change reported is the transition of Stanley Polomski from Senior Vice President & Controller to Senior Vice President, Business Process Optimization, effective September 22, 2025. Concurrently, Kelly L. Palumbo was appointed as Senior Vice President, Controller and Chief Accounting Officer, effective September 22, 2025.
Management Commentary and Compensation Details
Ms. Palumbo brings over two decades of experience from Johnson & Johnson and recent tenure at Charles River Laboratories International, Inc. Her compensation package includes:
- Base Salary: $410,000 per year.
- Annual Bonus: Target of 55% of base salary for fiscal 2026, subject to performance goals.
- Long-Term Incentive: Target award of 110% of base salary for fiscal 2026.
- One-Time Equity Grant: Restricted stock units valued at $200,000, vesting in three equal annual installments.
- Sign-on Cash Payment: $300,000 to offset forfeiture of prior employment bonuses and benefits.
- Benefits: Participation in standard employee programs and a $2,500 quarterly allowance under the Personal Choice Program.
No family relationships or reportable transactions under Item 404(a) of Regulation S-K were disclosed.
Investor Verification Checklist
- Verify the effective date of the leadership transition (September 22, 2025).
- Confirm the total value of the one-time cash payment and equity grant relative to the company's standard executive compensation policies.
- Review the 2024 Proxy Statement for details on the Personal Choice Program mentioned in the filing.
- Monitor future filings for any impact on internal controls or financial reporting timelines during the transition period.